Streetbeat News

Assets

HEPA

Hepion Pharmaceuticals shares are trading higher following the announcement of a definitive merger agreement with Pharma Two B and a $2.9 million private placement of non-convertible senior notes to institutional investors.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:22 pm

SANG

Sangoma Technologies Corporation (NASDAQ:SANG) announced a debt repayment of $5.3 million in Q4, totaling $9.7 million for the quarter. The company aims to reduce its debt to under $60 million by the end of Fiscal 2025, supported by a strong financial position.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:12 pm

HEPA

Pharma Two B is set to go public through a merger with Hepion Pharmaceuticals. Additionally, Hepion Pharmaceuticals announced a $2.9 million private placement of non-convertible senior notes to institutional investors.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:06 pm

QXO

QXO has closed a $3.5 billion private placement and expects to have $5 billion in cash and no debt after a new $620 million private placement closes on July 25. Additionally, Jared Kushner has joined the company's Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:03 pm

BTCUSD

ETHUSD

LTCUSD

SOLUSD

The Coinshares report reveals sustained inflows into Bitcoin and Ethereum investment products, with Bitcoin attracting $1.27 billion and Ethereum $45 million last week. Despite positive sentiment in digital assets, blockchain equities faced outflows of $8.5 million.

Portfolio Pulse from Murtuza Merchant

July 22, 2024 | 11:40 am

RDHL

Redhill Biopharma has terminated its agreement with Movantik Acquisition, Valinor Pharma, and Hcr Redhill, receiving approximately $9.9 million in cash and gaining full control over an additional $0.74 million held in a restricted account. The termination ends all existing credit ties with the agreement parties, removes the existing lien against Talicia®, and restores control over cash collections to Redhill.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:14 am

CLRB

Cellectar Biosciences (NASDAQ:CLRB) has generated $19.4M through the exercise of Tranche B warrants and the purchase of new warrants, with the potential to generate an additional $73.3M if the new warrants are exercised.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:52 am

CLW

Clearwater Paper has entered a definitive agreement to sell its tissue business to Sofidel America for $1.06 billion. The company expects net proceeds of approximately $850 million, which will be used to reduce debt and invest in growth initiatives. The transaction is expected to close in late 2024.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:12 am

HIVE

HIVE Digital is set to build a 100 MW data center in Paraguay, aiming to achieve a 12 EH/S hashrate and double its revenue.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:25 am

VZ

Top Wall Street analysts have updated their expectations for Verizon Communications Inc. (NYSE: VZ) ahead of its Q2 earnings release on July 22. Analysts predict a decrease in earnings per share from $1.21 to $1.15 year-over-year, while revenue is expected to increase slightly. Verizon is also considering selling thousands of mobile phone towers. Recent analyst ratings show mixed sentiments with price targets ranging from $40 to $52.

Portfolio Pulse from Avi Kapoor

July 22, 2024 | 5:57 am